Tablet compression is not only about the active pharmaceutical ingredient (API). Whether a tablet can be formed smoothly, avoid issues like sticking, capping, or lamination, and maintain the right balance of hardness and disintegration time depends largely on excipients. These auxiliary materials are the backbone of tablet formulation, ensuring manufacturability, stability, and therapeutic performance. In practice, four major excipient categories—fillers, binders, lubricants, and disintegrants—work in synergy, often supplemented by glidants when flowability is an issue. Understanding their functions and proper selection is critical for robust pharmaceutical development.

1. Fillers (Diluents): Building the Tablet Framework

Purpose: When the API has low dosage (below 10%), small bulk volume, or poor flow, fillers compensate by adding weight/volume and improving compressibility.

Key Options:

• Microcrystalline Cellulose (MCC): Outstanding compressibility, multifunctional (also acts as binder and disintegrant). Suitable for most tablets, especially those requiring high hardness.
• Lactose: Excellent flowability, stability, and palatability. Preferred in chewable and effervescent tablets.
• Starch: Cost-effective but moderate compressibility; usually combined with binders. Not suitable for acidic APIs.
• Mannitol: Non-hygroscopic, cooling mouthfeel, low caloric value. Ideal for chewable and lozenges.

2. Binders: Preventing Friability and Cracking

Purpose: Binders provide adhesive forces that hold powders or granules together, preventing friability ("soft tablets") and edge cracking. They can be incorporated intragranularly or extragranularly.

Key Options:

• Hydroxypropyl Methylcellulose (HPMC): Moderate adhesive strength, high stability. Used in conventional and sustained-release tablets.
• Polyvinylpyrrolidone (PVP): Strong binding, excellent solubility. Effective in both wet granulation and direct compression.
• Starch Paste (8–15% solution): Traditional, economical binder, though unsuitable for heat-sensitive APIs.
• Hydroxypropyl Cellulose (HPC): Strong binding and enhances flow, useful in both direct compression and granulation.

3. Lubricants: Ensuring Smooth Compression

Purpose: During compression, powders often adhere to punch surfaces ("sticking") or experience high inter-particle friction, causing weight variability. Lubricants reduce friction between particles and tooling, ensuring smooth ejection and glossy tablet surfaces.

Key Options:

• Magnesium Stearate: Extremely effective, requires low concentration (0.1–1%). Excess may slow dissolution, so use cautiously.
• Stearic Acid: Dual function—lubricant and anti-adhesive—with less dissolution impact. Usage 0.5–3%.
• Polyethylene Glycol (PEG 4000/6000): Water-soluble lubricant that does not hinder disintegration; ideal for effervescent and water-soluble tablets.

4. Disintegrants: Enabling Rapid Breakdown and Drug Release

Purpose: After ingestion, tablets must break down quickly to release the API. Disintegrants absorb water, swell, and cause the tablet to rupture into small granules.

Key Options:

• Cross-linked Polyvinylpyrrolidone (PVPP): High swelling capacity (300–500%), very rapid action. Works well for poorly soluble drugs.
• Cross-linked Carboxymethyl Cellulose Sodium (CCMC-Na): Strong, stable disintegration. Commonly used in both conventional and effervescent tablets.
• Sodium Starch Glycolate (CMS-Na): Rapid swelling, cost-effective. Popular in wet granulation tablets.

5. Glidants: Improving Powder Flowability

Purpose: For APIs or blends with poor flow, uneven die filling leads to weight variation. Glidants improve powder fluidity and ensure uniform dosing.

Key Options:

• Colloidal Silicon Dioxide: High surface area, excellent glidant effect. Used at 0.1–0.5%.
• Talc: Cost-effective, also provides anti-adhesion benefits. Typically 0.5–2%.

Practical Strategy: Balancing Compressibility, Flow, and Release

Fillers + Binders → Ensure compressibility and mechanical strength.

Lubricants + Glidants → Guarantee smooth operation and weight uniformity.

Disintegrants → Secure rapid breakdown and drug release.

In real production, excipient choice must be tailored to API properties (e.g., solubility, stability) and tablet type (e.g., chewable, conventional, sustained-release). Optimal results come from excipient synergy rather than single-component reliance.

- Contact us today for more information.